Metabolomic analysis sheds light on gut microbes’ role in cardiovascular disease risk

FHS
May 14, 2024
9:00 am

The effect of gut bacteria on non-high-density lipoprotein cholesterol (non-HDL-c) variations.

Strong operating cash flow – record figures as expected also for revenue and earnings in the third quarter of 2023 – Biotech Investments

EQS-News: Medios AG / Key word(s): Preliminary Results/9 Month figures Medios AG: Strong operating cash flow – record figures as expected also for revenue and

October 25, 2023

Cybin Finacial Analysis: Future Prospects are Uncertain | Psychedelic Invest

On Monday, Cybin released the financial results for its first quarter, ending June 30, 2023. As of June 30, 2023, the company had $9.4 million

August 16, 2023

Alzheimer’s Data Withdrawn

A preprint research letter linking the Alzheimer’s drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The preprint was posted on Research Square and

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.